Oct 26, 2026 04:00PM
Oct 8, 2026 03:00PM
Oct 8, 2026 08:30AM
Oct 8, 2026 02:30AM
Oct 8, 2026 02:30AM
Sep 28, 2026 08:00AM
Sep 28, 2026 08:00AM U.S. FDA Accepts sNDA and Grants Priority Review to Bayer’s Lynkuet® (elinzanetant) for a New Indication for the Treatment of Moderate to Severe Vasomotor Symptoms Due to Endocrine Therapy Related
Sep 17, 2026 02:30AM
Sep 17, 2026 02:30AM
Sep 9, 2026 10:22PM
Sep 9, 2026 10:21PM
Aug 30, 2026 07:45AM
Aug 20, 2026 08:00AM
Jul 28, 2026 08:00AM One A Day® Introduces New Women's Multi Gummy Formula with 1,000 mcg Biotin
Jul 2, 2026 08:00AM
Jun 15, 2026 02:30AM
Jun 15, 2026 02:30AM
Jun 5, 2026 06:40AM
Jun 2, 2026 08:00AM
May 21, 2026 08:00AM
May 21, 2026 08:00AM ASCO 2026: Bayer to Present New Data Across Oncology Portfolio
May 21, 2026 02:30AM
May 21, 2026 02:30AM
May 19, 2026 02:30AM
May 19, 2026 02:30AM
May 18, 2026 08:41AM
May 18, 2026 08:41AM
May 7, 2026 02:30AM Investigational PET Tracer Iodine 124 Evuzamitide from Bayer Met Primary Endpoints in Phase III Study in Patients Suspected to Have Cardiac Amyloidosis
Mar 26, 2026 09:55AM
Mar 16, 2026 03:30AM
Mar 4, 2026 08:00AM
Mar 4, 2026 08:00AM
Feb 23, 2026 10:28AM
Feb 5, 2026 12:15PM
Feb 5, 2026 12:15PM Bayer’s Asundexian Demonstrated a Substantial 26% Reduction in Stroke After a Non-Cardioembolic Ischemic Stroke or High-Risk Transient Ischemic Attack, With No Increase in ISTH Major Bleeding Versus
Jan 29, 2026 08:30AM
Jan 13, 2026 02:15PM
Jan 13, 2026 09:00AM
Jan 12, 2026 08:00AM
Dec 4, 2025 02:30AM
Dec 2, 2025 08:05AM
Dec 1, 2025 11:30AM Bayer’s MEDRAD® Centargo Multi-Patient CT Injection System Now With A Wider Range of Compatible CT Contrast Agents and Presentations
Nov 23, 2025 11:28AM
Nov 20, 2025 08:00AM
Nov 20, 2025 08:00AM
Nov 6, 2025 09:00AM
Oct 24, 2025 01:25PM
Oct 24, 2025 01:25PM
Oct 7, 2025 08:21AM One A Day® Unveils Bold New Brand Identity and Platform: “The ONE for you”
Oct 7, 2025 02:00AM

335,485 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All